US officials call for review of government-owned IP management

A US congressman and senator have asked the country’s audit institution, the Government Accountability Office (GAO) to review the management of government-owned IP in the health sector.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

China awards generics contracts to lowest bidders

26 September 2019 China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

Americas

Gilead challenges US govt patents on HIV drug Truvada

22 August 2019 Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

More on this story

Generics

China awards generics contracts to lowest bidders

26 September 2019 China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

Americas

Gilead challenges US govt patents on HIV drug Truvada

22 August 2019 Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

More on this story

Generics

China awards generics contracts to lowest bidders

26 September 2019 China’s drug pricing overhaul has seen the average cost of drugs drop by more than half, the country’s Joint Procurement Office announced this week.

Americas

Gilead challenges US govt patents on HIV drug Truvada

22 August 2019 Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.